Clinical Indication

Type 2 diabetes


Once a week preparation (Bydureon®) is formulary. Conditional on prescriber being trained to select and train patients. Use in conjunction with Updated Nice Clinical Guideline.


Twice daily preparation (Byetta®) is non formulary. However, existing  patients may remain on treatment

Date of classification

June 2015


Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.